tiprankstipranks
MusclePharm (MSLPQ)
OTHER OTC:MSLPQ
Holding MSLPQ?
Track your performance easily

MusclePharm (MSLPQ) Income Statement

23 Followers

MusclePharm Income Statement

Last quarter (Q4 2021), MusclePharm's total revenue was $13.10M, a decrease of -0.15% from the same quarter last year. In Q4, MusclePharm's net income was $-6.30M. See MusclePharm’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 50.02M$ 50.04M$ 64.44M$ 79.67M$ 88.11M$ 102.16M
Cost of Revenue
$ -46.83M$ -44.67M$ 44.83M$ -70.98M$ 69.72M$ -71.71M
Gross Profit
$ 3.19M$ 5.37M$ 19.61M$ 8.69M$ 18.39M$ 30.45M
Operating Expense
$ -14.86M$ -14.28M$ 17.01M$ -23.80M$ 26.23M$ -37.63M
Operating Income
$ -11.66M$ -8.91M$ 2.60M$ -15.11M$ -7.83M$ -7.01M
Net Non Operating Interest Income Expense
$ -9.10M$ -5.46M$ -1.49M$ -3.61M$ -3.78M$ -46.00K
Other Income Expense
$ -1.50M$ -1.50M$ -298.00K$ -29.61M$ 959.00K$ 3.64M
Pretax Income
$ -19.27M$ -12.87M$ 3.17M$ -18.84M$ -10.65M$ -10.83M
Tax Provision
$ -8.00K$ -8.00K$ -19.00K$ 86.00K$ 100.00K$ -108.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -19.26M$ -12.87M$ 1.50M$ -18.93M$ -10.76M$ -10.72M
Basic EPS
$ -0.58$ -0.39$ 0.10-$ -0.72-
Diluted EPS
$ -0.58$ -0.39$ 0.08$ -0.92$ -0.72$ -0.79
Basic Average Shares
$ 133.52M$ 33.36M$ 32.81M$ 20.48M$ 15.02M$ 13.88M
Diluted Average Shares
$ 132.29M$ 33.36M$ 41.17M$ 20.57M$ 15.02M-
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -61.69M$ -58.95M$ 61.84M$ -94.77M$ 95.94M$ -109.34M
Net Income From Continuing And Discontinued Operation
$ -19.26M$ -12.87M$ 3.19M$ -18.93M$ -10.76M$ -10.72M
Normalized Income
----$ -10.67M-
Interest Expense
----$ 3.80M-
EBIT
$ -10.17M$ -7.41M$ 4.66M$ -16.63M$ -6.86M$ -10.79M
EBITDA
$ -4.97M$ -4.79M$ 5.12M$ -15.91M$ -6.01M$ -11.88M
Currency in USD

MusclePharm Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis